Form 4: Quest Diagnostics SVP Patrick Plewman Reports Stock Acquisition and Disposals

Patrick Plewman, SVP for Diagnostic Services at Quest Diagnostics, reports acquiring and disposing of common stock.

Summary

• Patrick Plewman, a Senior Vice President at Quest Diagnostics, filed a Form 4 detailing changes in beneficial ownership of the company's stock.
• On July 22, 2024, Plewman acquired 60 shares of common stock through a dividend reinvestment plan at a price of $146.974 per share.
• Plewman also reported disposals.
• Following these transactions, Plewman beneficially owns 16,162 shares of Quest Diagnostics common stock.
• The reported amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard regulatory filing detailing stock transactions. There's no inherent positive or negative implication.

Positives

• The reporting person's participation in the dividend reinvestment plan indicates a continued investment in the company's stock.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities, which can be of interest to investors.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider trading activity.

Key Dates